TNFRSF17 and non-small cell lung carcinoma: In combination with the inconsistent prognosis value of BCMA and APRIL, we predict that BCMA is not only a APRIL receptor, but may play other important roles in NSCLC and take participate in the regulation of other signaling pathways.